We are live on ! Find out more
RGN

REGENERX BIOPHARMACEUTICALS
RGN

Delisted

RGN was delisted on the 22nd of December, 2010.

Back to rankings

1 hedge funds and large institutions have $23K invested in REGENERX BIOPHARMACEUTICALS in 2015 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more capital invested

Capital invested by funds: $16K → $23K (+$7K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DBIA
1
Dumont & Blake Investment Advisors
New Jersey
$23K – – –

RGN Hedge Fund Activity: Q2 2015 in Review

1 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in REGENERX BIOPHARMACEUTICALS (RGN) for Q2 2015, worth a combined $23K — up 44% from $16K a quarter earlier.

Fund positioning in RGN was balanced in Q2 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held REGENERX BIOPHARMACEUTICALS (RGN) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $23K of REGENERX BIOPHARMACEUTICALS stock for Q2 2015, up 44% quarter-over-quarter.
  • 0 funds opened new REGENERX BIOPHARMACEUTICALS positions in Q2 2015 and 0 closed out.

Based on aggregated 13F filings for Q2 2015.